A few months after a key label expansion, AstraZeneca’s asthma treatment Fasenra has received FDA approval to treat a rare ...
The Federal Reserve made its long-anticipated interest rate cuts on Wednesday, lowering rates by a half of a percentage point ...
Keytruda is already approved in more than 40 different oncology indications, but its latest label expansion is a first for ...
Sen. Marco Rubio (R-FL) and Sen. Angus King (I-ME) have told the FDA that “considerable work” needs to be done to ...
Roivant is once again reaping the benefits of its bespoke business model. This time, it's selling Dermavant to Organon for up ...
Insilico Medicine reported Phase 2a results for its lead program, saying the study achieved its primary endpoint of safety ...
Novo Nordisk is doubling down on its investment in genetic medicine-based biotechs, inking a new collaboration with a lipid ...
A startup in Brazil that lets people easily buy medicine online by combining a consumer-friendly experience with prescription ...
Another pharma company is facing supply constraints because of third-party contract manufacturing issues. On Tuesday, Theratechnologies warned there is a risk its ...
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get ...
Novartis was already riding a wave of momentum with Kisqali, and now it has a new FDA nod to break into the early breast ...
The FDA on Tuesday firmed up its position that in some limited circumstances, clinical trial data may be obtained from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback